#aging

LIVE PULSE

3.9 Anthropic CEO Amodei calls for slower AI development and shared safety rules — 11 src2.1 Agility Robotics unveils Digit 5 humanoid for warehouses and factories — 2 src2.0 Apple ships rebuilt Siri with Google Gemini, but not in the EU — 2 src1.7 Siri AI in macOS 27 Golden Gate: FAQ, Germany availability, privacy questions — 2 src1.4 Sam Altman says OpenAI will not go public in 2026, citing AI safety concerns — 5 src1.1 OpenAI contractors review real ChatGPT conversations to rate responses, report says — 2 src1.1 Anthropic data retention policy prompts firms to limit Claude use for sensitive work — 1 src1.1 Study examines issue bias in LLMs used as writing assistants before Swedish 2026 election — 1 src1.1 Study Audits Misalignment in Multi-Modal World Models — 1 src1.1 Retrieval-Grounded Reasoning Approach Proposed for Universal Multimodal Embeddings — 1 src3.9 Anthropic CEO Amodei calls for slower AI development and shared safety rules — 11 src2.1 Agility Robotics unveils Digit 5 humanoid for warehouses and factories — 2 src2.0 Apple ships rebuilt Siri with Google Gemini, but not in the EU — 2 src1.7 Siri AI in macOS 27 Golden Gate: FAQ, Germany availability, privacy questions — 2 src1.4 Sam Altman says OpenAI will not go public in 2026, citing AI safety concerns — 5 src1.1 OpenAI contractors review real ChatGPT conversations to rate responses, report says — 2 src1.1 Anthropic data retention policy prompts firms to limit Claude use for sensitive work — 1 src1.1 Study examines issue bias in LLMs used as writing assistants before Swedish 2026 election — 1 src1.1 Study Audits Misalignment in Multi-Modal World Models — 1 src1.1 Retrieval-Grounded Reasoning Approach Proposed for Universal Multimodal Embeddings — 1 src

1 curated events

papersSEP 9 10:58 UTC

AI-designed lung fibrosis drug linked to slower biological aging in trial

A drug candidate for lung fibrosis that was developed with the help of artificial intelligence produced effects in a study that point to a reduced pace of biological aging. The reported findings come from a single trial and indicate additional effects beyond the compound's intended antifibrotic action. Researchers have not yet established whether these observations translate into clinical benefits for patients.

drug-discovery/ai-biotech/clinical-trial/aging